Breastfeeding while taking seizure medicine does not appear to harm children

April 17, 2008

CHICAGO - A first of its kind study finds breastfeeding while taking certain seizure medications does not appear to harm a child's cognitive development. The research will be presented at the upcoming American Academy of Neurology 60th Anniversary Annual Meeting in Chicago, April 12-19, 2008.

"Our early findings show breastfeeding during anti-epilepsy drug treatment doesn't appear to have a negative impact on a child's cognitive abilities," said study author Kimford Meador, MD, with the University of Florida at Gainesville, and Fellow of the American Academy of Neurology. "However, more research is needed to confirm our findings and women should use caution due to the limitations of our study."

Researchers tested the cognitive development of 187 two-year-old children whose mothers were taking the epilepsy drugs lamotrigine, carbamazepine, phenytoin, or valproate. Forty-one percent of the children were breastfed.

The study found breastfed children had higher cognitive test scores than those children who were not breastfed, and this trend was consistent for each anti-epilepsy drug. The children who were breastfed received an average test score of 98.1 compared to a score of 89.5 for the children not breastfed. However, the results were not significant after adjusting for the mother's IQ. Thus, it appears that the higher scores in children who were breastfed is due to the fact that their mothers had higher IQs.

Meador says animal studies have shown that some anti-epilepsy drugs, but not all, can cause cells to die in immature brains, but this effect can be blocked by the protective effects of beta estradiol, which is the mother's sex hormone. "Since the potential protective effects of beta estradiol in utero are absent after birth, concern was raised that breastfeeding by women taking anti-epilepsy drugs may increase the risk of anti-epilepsy drug-induced cell death and result in reduced cognitive outcomes in children."

Meador says additional research on the effects of breastfeeding should be extended to other anti-epilepsy drugs and mothers who use more than one anti-epilepsy medication.

The study is part of an ongoing study of the long-term effects of in utero anti-epilepsy drug exposure on children's cognition. Women with epilepsy who were taking anti-epilepsy drugs were enrolled in the study during pregnancy. Ultimately, the study will examine the effects of in utero anti-epilepsy drug exposure on children at six years old.
-end-
The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, epilepsy, multiple sclerosis, Parkinson's disease, and stroke.

For more information about the American Academy of Neurology, visit www.aan.com.

Editor's Note: Dr. Meador will present this research during a scientific platform session at 1:30 p.m. CT/2:30 p.m. ET, on Thursday, April 17, 2008, in Room 190 B of the McCormick Place West Convention Center.

American Academy of Neurology

Related Breastfeeding Articles from Brightsurf:

New guidelines say breastfeeding is safe after anaesthesia
New guidelines published by the Association of Anaesthetists in the journal Anaesthesia, to coincide with the start of World Breast Feeding Week (1-7 August) say that breastfeeding is safe after the mother has had anaesthesia, as soon as she is alert and able to feed.

New protocol on breast cancer and breastfeeding
Managing women with breast cancer who are breastfeeding is a complex issue.

Is it safe to vape while breastfeeding?
Findings from a new animal study suggest that maternal nicotine exposure during breastfeeding could be linked to problems with skull and face development.

Breastfeeding benefits during COVID-19
While the current coronavirus pandemic continues to affect all people, families will still give birth and bring new life into the world.

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

Coronavirus treatment and risk to breastfeeding women
Little data is available about the ability of antiviral drugs used to treat COVID-19, coronavirus, to enter breastmilk, let alone the potential adverse effects on breastfeeding infants.

Managing cannabis use in breastfeeding women
As more states legalize medicinal and recreational cannabis use and increasingly decriminalize cannabis, the risk to the growth and development of breastfeeding infants whose mothers use cannabis becomes a growing public health concern.

New recommendations released on bedsharing to promote breastfeeding
Leading experts representing The Academy of Breastfeeding Medicine (ABM) have released new evidence-based recommendations regarding the benefits and risks of bedsharing for mother-infant pairs who have initiated breastfeeding and are in home settings.

Apps help with breastfeeding -- at a cost
Mobile phone apps are increasingly being used to support breastfeeding decisions - sometimes at a cost, a Flinders University study indicates.

Breastfeeding disparities among us children by race/ethnicity
Overall rates of breastfeeding increased from 2009 to 2015 but they varied by race/ethnicity in this observational study that used national survey data for nearly 168,000 infants in the United States.

Read More: Breastfeeding News and Breastfeeding Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.